News
-
-
PRESS RELEASE
Just – Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access
Just - Evotec Biologics, a subsidiary of Evotec SE, receives grant from Gates Foundation to optimize monoclonal antibody development using AI-driven molecular design, enhancing affordability and global access -
-
-
-
-
-
-
-
PRESS RELEASE
Evotec receives milestone payment from Bristol Myers Squibb following IND acceptance in strategic protein degradation partnership
Evotec receives US$ 5m milestone payment from Bristol Myers Squibb for IND acceptance in protein degradation partnership, advancing drug candidate towards Phase 1 clinical trial
